3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
2
Phase NA
1
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Breast
1
Conditions
Polycystic Ovary Syndrome
1
Obesity
1
Lipid Metabolism Disorders
1
Diabetes Mellitus
1
Cardiovascular Diseases
1
Interventions
Metformin
2
rosiglitazone-metformin combination
1
mirabegron
1
lorcaserin
1
exemestane
1
atezolizumab
1
angiotensin I (1-7)
1
Traumeel S
1
Tirzepatide
1
TIC10 compound
1
Sodium Chloride
1
Rosiglitazone
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy
1
Melphalan
1
Leflunomide
1
Hydroquinones
1
Fish Oils
1
Fibroblast Growth Factor 7
1
Drug Therapy
1
Docosahexaenoic Acids
1
Cisplatin
1
Cholestyramine Resin
1
CBLB502
1
Ascorbic Acid
1
Acupuncture Therapy
1
ART123
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Docosahexaenoic Acids
×
Other
×
Clear all
NCT04116203
2025-02-28
PCOS
University of Alberta
Phase 1
Completed
52 enrolled